EMEA-002600-PIP01-19

Key facts

Active substance
Pegcetacoplan
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0149/2020
PIP number
EMEA-002600-PIP01-19
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of paroxysmal nocturnal haemoglobinuria
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Apellis Ireland Limited

E-mail:j.collins@mdlpharma.co.uk
Tel. + 44 1386438358

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating